During the past decade, Hospital Rawson conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Rawson" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "University of Minnesota" with 3 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "AiCuris Anti-infective Cures AG" with 1 trials sponsored and "Corvus Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Rawson" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Rawson" are "HIV Infections" (2 trials), "Influenza" (2 trials), "Influenza A" (2 trials), "COVID-19 Infection" (1 trials) and "Covid-19" (1 trials). Many other conditions were trialed in "Hospital Rawson" in a lesser frequency.

Most popular intervention types in "Hospital Rawson" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pimodivir 600 mg" (2 trials), "Remdesivir" (2 trials), "SOC Treatment" (2 trials) and "2N(t)RTI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Rawson" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Rawson". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital Rawson, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Rawson, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".